Dried Flower |
| |||
293 of 777 products in Dried Flower |
THC | 140 - 200mg/g (~17%) | VERY STRONG | 0 - 5mg/g (~0.2%) | CBD |
eweed.pro | HYBRID | csmeter © |
2.5 ★★ (10)★ ☆ ☆☆ |
$9.56* 1g |
Pine |
AROMA / FLVR |
||
+Pepper | +Herbal |
Inflammation |
AID** WITH |
||
+Relaxation | +Antiseptic |
Potency | Very Strong | |
THC | 140 - 200mg/g | (14% - 20%) |
CBD | 0 - 5mg/g | (0% - 0%) |
Plant Type | Hybrid | |
Strain(s) | Lemon Skunk | |
Grown In | Smiths Falls, ON | |
Method | GREENHOUSE | |
Producer | DNA Genetics by Canopy Growth Corp. | |
GTIN# | 00688083000164 (1g) 00688083000188 (3.5g) 00688083000201 (7g) 00688083000171 (15g) |
|
Terpenes | Bergamotene, Beta-Pinene, Para-Cymenene, Terpinolene, Trans-Caryophyllene |
Lemon Skunk dried flower by DNA Genetics is a greenhouse-grown hybrid strain with medium THC potency. The plant's buds are light green with thick orange hairs, and its terpene profile is rich in bergamotene, terpinolene and caryophyllene, which give it a black pepper scent and hints of citrus. Available in various dried flower weights and capsules.
DNA Genetics; perhaps one of the most well known and regarded cannabis brands in the world was established over thirteen years ago in Amsterdam. At the time it was the only market that provided a place for legal and commercial cannabis activity. During this period DNA Genetics were able to develop their brand as well as influence the global market, developing high quality seeds directly from California to the then only legal market in the entire world. After having spent more than a decade building the brand in the European marketplace DNA has simultaneously been developing strategic partnerships throughout the world, directly entering into each legal market as the laws in each territory changed to provide for legal cannabis enterprises. DNA Genetics intentions have not changed from the moment the company was created and will continue to provide and supply the highest quality cannabis seeds for the medicinal and recreational markets.
About Canopy Growth
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.